We are analyzing https://link.springer.com/article/10.1007/s00262-019-02415-8.

Title:
Autophagy inhibition induces the repolarisation of tumour-associated macrophages and enhances chemosensitivity of laryngeal cancer cells to cisplatin in mice | Cancer Immunology, Immunotherapy
Description:
Tumour-associated macrophages (TAMs) are the key components in the tumour microenvironment. TAMs have two major subtypes, M1 and M2. M1 macrophages are tumour inhibitory, while M2 macrophages are tumour promotive. Repolarising TAMs from M2 to M1 is a promising strategy in cancer treatment. M1 and M2 macrophages were generated from murine bone marrow-derived macrophages (BMDMs). We found that chloroquine (CQ), an autophagy inhibitor, was able to repolarise M2 macrophages to the anti-tumour M1 phenotype. The repolarised macrophages demonstrated higher phagocytotic activity towards Hep-2 laryngeal tumour cells and re-sensitised Hep-2 cells to cisplatin (CDDP) treatment in vitro. While CQ did not demonstrate cytotoxicity to Hep-2 cells in vitro, CQ treatment reduced Hep-2 laryngeal tumour growth in vivo and improved CDDP treatment outcomes. It seems that CQ-induced M2-to-M1 macrophage repolarisation played an important role in tumour growth inhibition, and the CQ/CDDP combined therapy might have clinical potential in laryngeal cancer treatment.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Science
Education
Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

The income method remains a mystery to us.

Earning money isn't the goal of every website; some are designed to offer support or promote social causes. People have different reasons for creating websites. This might be one such reason. Link.springer.com could have a money-making trick up its sleeve, but it's undetectable for now.

Keywords {🔍}

article, pubmed, google, scholar, cas, macrophages, cancer, central, autophagy, cell, tumorassociated, cells, macrophage, shandong, inhibition, laryngeal, wang, polarization, chen, tumourassociated, tumour, httpsdoiorgs, enhances, mice, treatment, hep, access, tumor, carcinoma, nat, privacy, cookies, content, guo, immunol, lin, nature, data, information, publish, search, immunotherapy, repolarisation, cisplatin, pan, tams, chloroquine, liu, huang, biol,

Topics {✒️}

tlr7/8-agonist-loaded nanoparticles promote gfp-labelled hep-2-gfp cells month download article/chapter cancer stem/initiating cells nu/nu nude mice suppress oxaliplatin-induced apoptosis gut microbiota-stimulated cathepsin wnt/beta-catenin pathway sensitizes pten-null tumors cq/cddp combined therapy anti-tumour m1 phenotype tumour-derived lactic acid article cancer immunology imaging tumor-stroma interactions supraglottic laryngeal carcinoma full article pdf related subjects laryngeal cancer cells targeted cancer immunotherapy sensitised hep-2 cells cytotoxic m1 phenotype laryngeal cancer treatment autophagy inhibition induces privacy choices/manage cookies macrophages suppress antitumor tumour growth inhibition bak-dependent autophagy myc-induced model lipopolysaccharide m-csf hepatocellular carcinoma article guo tnf-alpha derived pn0 pancreatic cancer chemotherapy reveals contributions enhance cancer immunotherapy cq-induced m2 cell death differ immune cells troika governing cancer improves chemotherapeutic responses promotes tumor metastasis synergistically enhances ddp osu-03012 enhances ad exp cell res european economic area von roemeling ca simple practice guide regional lymph nodes perez daghastanli kr blocks glioma progression

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Autophagy inhibition induces the repolarisation of tumour-associated macrophages and enhances chemosensitivity of laryngeal cancer cells to cisplatin in mice
         description:Tumour-associated macrophages (TAMs) are the key components in the tumour microenvironment. TAMs have two major subtypes, M1 and M2. M1 macrophages are tumour inhibitory, while M2 macrophages are tumour promotive. Repolarising TAMs from M2 to M1 is a promising strategy in cancer treatment. M1 and M2 macrophages were generated from murine bone marrow-derived macrophages (BMDMs). We found that chloroquine (CQ), an autophagy inhibitor, was able to repolarise M2 macrophages to the anti-tumour M1 phenotype. The repolarised macrophages demonstrated higher phagocytotic activity towards Hep-2 laryngeal tumour cells and re-sensitised Hep-2 cells to cisplatin (CDDP) treatment in vitro. While CQ did not demonstrate cytotoxicity to Hep-2 cells in vitro, CQ treatment reduced Hep-2 laryngeal tumour growth in vivo and improved CDDP treatment outcomes. It seems that CQ-induced M2-to-M1 macrophage repolarisation played an important role in tumour growth inhibition, and the CQ/CDDP combined therapy might have clinical potential in laryngeal cancer treatment.
         datePublished:2019-10-22T00:00:00Z
         dateModified:2019-10-22T00:00:00Z
         pageStart:1909
         pageEnd:1920
         sameAs:https://doi.org/10.1007/s00262-019-02415-8
         keywords:
            Chloroquine (CQ)
            Tumour-associated macrophages (TAMs)
            Autophagy inhibition
            Macrophage repolarisation
            Hep-2 laryngeal cancer
            Oncology
            Immunology
            Cancer Research
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-019-02415-8/MediaObjects/262_2019_2415_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-019-02415-8/MediaObjects/262_2019_2415_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-019-02415-8/MediaObjects/262_2019_2415_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-019-02415-8/MediaObjects/262_2019_2415_Fig4_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-019-02415-8/MediaObjects/262_2019_2415_Fig5_HTML.png
         isPartOf:
            name:Cancer Immunology, Immunotherapy
            issn:
               1432-0851
               0340-7004
            volumeNumber:68
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer Berlin Heidelberg
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Ying Guo
               affiliation:
                     name:Shandong University
                     address:
                        name:Department of Otorhinolaryngology, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yufang Feng
               affiliation:
                     name:Weifang Yidu Central Hospital
                     address:
                        name:Department of Otorhinolaryngology, Weifang Yidu Central Hospital, Weifang, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Xinhua Cui
               affiliation:
                     name:Shandong University
                     address:
                        name:Department of Otorhinolaryngology, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Qirong Wang
               affiliation:
                     name:Shandong University
                     address:
                        name:Department of Otorhinolaryngology, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Xinliang Pan
               affiliation:
                     name:Shandong University
                     address:
                        name:Department of Otorhinolaryngology, Qilu Hospital, Shandong University, Jinan, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Autophagy inhibition induces the repolarisation of tumour-associated macrophages and enhances chemosensitivity of laryngeal cancer cells to cisplatin in mice
      description:Tumour-associated macrophages (TAMs) are the key components in the tumour microenvironment. TAMs have two major subtypes, M1 and M2. M1 macrophages are tumour inhibitory, while M2 macrophages are tumour promotive. Repolarising TAMs from M2 to M1 is a promising strategy in cancer treatment. M1 and M2 macrophages were generated from murine bone marrow-derived macrophages (BMDMs). We found that chloroquine (CQ), an autophagy inhibitor, was able to repolarise M2 macrophages to the anti-tumour M1 phenotype. The repolarised macrophages demonstrated higher phagocytotic activity towards Hep-2 laryngeal tumour cells and re-sensitised Hep-2 cells to cisplatin (CDDP) treatment in vitro. While CQ did not demonstrate cytotoxicity to Hep-2 cells in vitro, CQ treatment reduced Hep-2 laryngeal tumour growth in vivo and improved CDDP treatment outcomes. It seems that CQ-induced M2-to-M1 macrophage repolarisation played an important role in tumour growth inhibition, and the CQ/CDDP combined therapy might have clinical potential in laryngeal cancer treatment.
      datePublished:2019-10-22T00:00:00Z
      dateModified:2019-10-22T00:00:00Z
      pageStart:1909
      pageEnd:1920
      sameAs:https://doi.org/10.1007/s00262-019-02415-8
      keywords:
         Chloroquine (CQ)
         Tumour-associated macrophages (TAMs)
         Autophagy inhibition
         Macrophage repolarisation
         Hep-2 laryngeal cancer
         Oncology
         Immunology
         Cancer Research
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-019-02415-8/MediaObjects/262_2019_2415_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-019-02415-8/MediaObjects/262_2019_2415_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-019-02415-8/MediaObjects/262_2019_2415_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-019-02415-8/MediaObjects/262_2019_2415_Fig4_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-019-02415-8/MediaObjects/262_2019_2415_Fig5_HTML.png
      isPartOf:
         name:Cancer Immunology, Immunotherapy
         issn:
            1432-0851
            0340-7004
         volumeNumber:68
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer Berlin Heidelberg
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Ying Guo
            affiliation:
                  name:Shandong University
                  address:
                     name:Department of Otorhinolaryngology, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yufang Feng
            affiliation:
                  name:Weifang Yidu Central Hospital
                  address:
                     name:Department of Otorhinolaryngology, Weifang Yidu Central Hospital, Weifang, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Xinhua Cui
            affiliation:
                  name:Shandong University
                  address:
                     name:Department of Otorhinolaryngology, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Qirong Wang
            affiliation:
                  name:Shandong University
                  address:
                     name:Department of Otorhinolaryngology, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Xinliang Pan
            affiliation:
                  name:Shandong University
                  address:
                     name:Department of Otorhinolaryngology, Qilu Hospital, Shandong University, Jinan, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Cancer Immunology, Immunotherapy
      issn:
         1432-0851
         0340-7004
      volumeNumber:68
Organization:
      name:Springer Berlin Heidelberg
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Shandong University
      address:
         name:Department of Otorhinolaryngology, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, China
         type:PostalAddress
      name:Weifang Yidu Central Hospital
      address:
         name:Department of Otorhinolaryngology, Weifang Yidu Central Hospital, Weifang, China
         type:PostalAddress
      name:Shandong University
      address:
         name:Department of Otorhinolaryngology, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, China
         type:PostalAddress
      name:Shandong University
      address:
         name:Department of Otorhinolaryngology, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, China
         type:PostalAddress
      name:Shandong University
      address:
         name:Department of Otorhinolaryngology, Qilu Hospital, Shandong University, Jinan, China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Ying Guo
      affiliation:
            name:Shandong University
            address:
               name:Department of Otorhinolaryngology, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, China
               type:PostalAddress
            type:Organization
      name:Yufang Feng
      affiliation:
            name:Weifang Yidu Central Hospital
            address:
               name:Department of Otorhinolaryngology, Weifang Yidu Central Hospital, Weifang, China
               type:PostalAddress
            type:Organization
      name:Xinhua Cui
      affiliation:
            name:Shandong University
            address:
               name:Department of Otorhinolaryngology, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, China
               type:PostalAddress
            type:Organization
      name:Qirong Wang
      affiliation:
            name:Shandong University
            address:
               name:Department of Otorhinolaryngology, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, China
               type:PostalAddress
            type:Organization
      name:Xinliang Pan
      affiliation:
            name:Shandong University
            address:
               name:Department of Otorhinolaryngology, Qilu Hospital, Shandong University, Jinan, China
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Otorhinolaryngology, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, China
      name:Department of Otorhinolaryngology, Weifang Yidu Central Hospital, Weifang, China
      name:Department of Otorhinolaryngology, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, China
      name:Department of Otorhinolaryngology, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, China
      name:Department of Otorhinolaryngology, Qilu Hospital, Shandong University, Jinan, China
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(192)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

5.79s.

LINK . SPRINGER . COM {}